Litcius/Paper detail

Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial

Lisa Noguchi, Maxensia Owor, Nyaradzo Mgodi, Brenda Gati Mirembe, Sufia Dadabhai, Elizea Horne, Holly Gundacker, Barbra A. Richardson, Katherine Bunge, Rachel Scheckter, Mei Song, Mark A. Marzinke, Peter L. Anderson, Edward Livant, Cindy Jacobson, Jeanna Piper, Nahida Chakhtoura, Sharon L. Hillier, Jennifer E. Balkus

2025The Lancet HIV11 citationsDOIOpen Access PDF

Topics & Concepts

MedicineBreastfeedingVaginal ringOpen labelObstetricsPediatricsRandomized controlled trialEnvironmental healthFamily planningSurgeryPopulationResearch methodologyHIV/AIDS Research and InterventionsHIV/AIDS drug development and treatmentReproductive tract infections research
Safety and drug quantification of the dapivirine vaginal ring and oral pre-exposure prophylaxis in breastfeeding mother–infant pairs (MTN-043): a phase 3B, open-label, randomised trial | Litcius